Pharmacy Choice - Pharmaceutical News - Watson Confirms Favorable Appeals Court Decision in Mucinex Patent Suit - July 18, 2011

Watson Pharmaceuticals, Inc. (NYSE: WPI) confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex (Guaifenesin), Mucinex D (Pseudoephedrine/Guaifenesin), and Mucinex DM (Dextromethorphan HBr/ Guaifenesin)...